WHIPPANY, N.J. — Bayer has introduced Aspirina, Mexico’s top-selling pain relief brand, to the United States, aiming to connect with Hispanic consumers who have long relied on the product in their home countries.
Aspirina has been a trusted name in Mexico for generations, with a 99 percent brand awareness rate and 67 percent of consumers using it regularly. Bayer said the U.S. launch is designed to meet the needs of the country’s growing Hispanic population, which represents 19 percent of Americans today and is projected to reach 28 percent by 2060.
“Many Hispanic communities still face inadequate access to healthcare and consumer goods,” said Mohamed Atef, global brand lead for Aspirin at Bayer. “By adding Aspirina to the U.S. portfolio, we are placing the consumer at the center of our strategy. Data shows that 70 percent of Hispanic consumers feel a strong connection to their country of origin, making it essential for brands to honor and reflect this sentiment.”
For many Hispanic families in the U.S., Aspirina carries a sense of trust and nostalgia, as parents and grandparents have used it for decades. Bayer, which invented modern aspirin 125 years ago, says the brand continues to be one of the most trusted names in pain relief in the United States.
Aspirina is now available at select Walmart and Walgreens locations across the country.
